ELDN
Eledon Pharmaceuticals Inc
2.50$
+1.2%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | 100.0% | – | 100.0% | – | – | – | – | – | – | – | |
| – | – | – | 17.3% | – | 22.9% | – | – | – | – | – | – | – | |
| – | – | – | -17.3% | – | -22.9% | – | – | – | – | – | – | – | |
| – | – | – | 1,804.6% | – | 4,668.8% | – | – | – | – | – | – | – | |
| – | – | – | 785.0% | – | 1,762.5% | – | – | – | – | – | – | – | |
| – | – | – | 2,589.6% | – | 6,431.3% | – | – | – | – | – | – | – | |
| – | – | – | -2,589.6% | – | -6,431.3% | – | – | – | – | – | – | – | |
| – | – | – | 60.4% | – | – | – | – | – | – | – | – | – | |
| – | – | – | -8,019.1% | – | -11,506.8% | – | – | – | – | – | – | – | |
| – | – | – | 9.2% | – | 112.2% | – | – | – | – | – | – | – | |
| – | – | – | -8,019.1% | – | -11,619.0% | – | – | – | – | – | – | – | |
| – | – | – | -8,001.8% | – | -11,483.9% | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.